Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Innovation Industries
AmsterdamSeed–Growth$2.2M – $54M
25 people
Merit Capital Partners
ChicagoGrowth$20M
22 people
International Finance Corporation
Washington D.C.Series A–Late Stage
24 people
Novartis Venture Fund
BaselSeed–Growth$5M – $25M
21 people
Rakuten Capital
TokyoSeed–Late Stage
21 people
Spring Marketing Capital
Seed–Growth
24 people
Viola Credit
Tel AvivGrowth–Late Stage
41 people
Red River West
Paris, Ile-De-FrancePre-Seed–Late Stage$5.4M – $54M
33 people
KDDI Open Innovation Fund
Seed–Growth
1 person
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
Ysios Capital
BarcelonaSeed–Growth$5.4M – $21.6M
26 people
Kaiser Permanente Ventures
San FranciscoSeed–Growth$2M – $5M
13 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Growth
29 people
BCI
VictoriaGrowth–Late Stage
13 people
First Analysis
ChicagoGrowth$3M – $10M
24 people
Equistone Partners Europe
LondonGrowth$27M – $216M
4 people
Lumira Ventures
TorontoSeed–Growth$1M – $10M
17 people
NaviMed Capital
RosslynGrowth$5M – $30M
30 people
SEAF
WashingtonGrowth$3M – $7M
33 people
World Innovation Lab
Palo AltoGrowth–Late Stage
30 people
Karista
ParisPre-Seed–Growth$324K – $5.4M
12 people
Palamon Capital Partners
LondonGrowth
29 people
Souter Investments
EdinburghGrowth–Late Stage$2.5M – $38M
13 people
Ziegler Link-age Funds
ChicagoGrowth
40 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.



































































































